Skip to main content

and
  1. Article

    Open Access

    Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase

    Lactate dehydrogenase (LDH) in serum has recently been introduced into the American Joint Committee on Cancer (AJCC) staging system for cutaneous melanoma because of its prognostic value. We hypothesised LDH t...

    M Deichmann, B Kahle, K Moser, J Wacker, K Wüst in British Journal of Cancer (2004)

  2. No Access

    Article

    Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation

    Monitoring of gene and protein expression in peripheral blood cells has significant potential for improving the diagnosis and therapy of many human diseases. As genomic-scale microarray and proteomic technolog...

    E C Baechler, F M Batliwalla, G Karypis, P M Gaffney, K Moser in Genes & Immunity (2004)

  3. No Access

    Article

    Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants

    We analyzed toxicity and efficacy of chemotherapy (CT) or second stem cell transplantation (SCT) and/or immunotherapy defined as stop of immunosuppression (IS) or donor leukocyte infusion (DLI) in 47 patients ...

    F Keil, E Prinz, P Kalhs, K Lechner, K Moser, I Schwarzinger, U Jäger in Leukemia (2001)

  4. No Access

    Article

    Toxicity and response to high-dose ifosfamide+mesna as salvage therapy for advanced breast cancer

    Twenty-six cycles of high-dose ifosfamide+mesna (HD-IFO+M) were applied to seven female patients with advanced breast cancer refractory to prior treatment, using three different durations of continuous infusio...

    G. G. Steger, C. Dittrich, O. Schlappack in Journal of Cancer Research and Clinical On… (1988)

  5. Article

    Results of a four-year prospective randomised study of operable breast cancer

    R. Kolb, K. Kühnl-Brady, R. Jakesz, K. Moser in Journal of Cancer Research and Clinical On… (1986)

  6. No Access

    Article

    The human tumour cloning assay in the management of breast cancer patients

    A tumour cloning system was used to cultivate breast cancer specimens. Fifty-six percent of 87 samples were adequate for evaluation, showing clonal growth in about one third (35%). Effusions yielded significan...

    C Dittrich, R Jakesz, F Wrba, L Havelec, O Haas, J Spona in British Journal of Cancer (1985)

  7. No Access

    Article

    Acute cardiac toxicity in patients after doxorubicin treatment and the effect of combined tocopherol and nifedipine pretreatment

    In two groups of female patients with metastatic breast cancer who had all been pretreated with doxorubicin (350 mg/m2), acute cardiac effects following i.v. doxorubicin bolus injection (60 mg/m2) were recorded o...

    R. Lenzhofer, U. Ganzinger, H. Rameis in Journal of Cancer Research and Clinical On… (1983)

  8. No Access

    Article

    Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy

    Ninety-eight female patients (mean age 54 years) who underwent doxorubicin therapy because of metastatic breast cancer were submitted to radionuclide angiography at rest. Left ventricular ejection fractions (L...

    R. Lenzhofer, R. Dudczak, G. Gumhold in Journal of Cancer Research and Clinical On… (1983)

  9. No Access

    Article

    The value of prognostic parameters for the stratification of advanced breast cancer patients

    One hundred seventy-five patients with metastatic breast cancer, treated with a combination chemotherapy (Cooper regimen), were analyzed retrospectively to identify the value of the traditional prognostic para...

    R. Mörz, M. Francesconi, M. Schemper in Journal of Cancer Research and Clinical On… (1982)